We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+4.51%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$912M
AUM Growth
+$112M
Cap. Flow
+$107M
Cap. Flow %
11.78%
Top 10 Hldgs %
35.88%
Holding
80
New
13
Increased
28
Reduced
21
Closed
12

Top Buys

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$18.6M
2
ARRY
Array Biopharma Inc
ARRY
+$16.5M
3
GILD icon
Gilead Sciences
GILD
+$16.3M
4
PRAH
PRA Health Sciences, Inc.
PRAH
+$13.4M
5
ALDR
Alder Biopharmaceuticals
ALDR
+$12.5M

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$20.7M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$14.8M
3
GBT
Global Blood Therapeutics, Inc.
GBT
+$14.2M
4
LOXO
Loxo Oncology, Inc
LOXO
+$12.8M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$9.64M

Sector Composition

Rank Sector Weight
1 Healthcare 91.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRTA icon
76
Prothena Corp
PRTA
$440M
– –
-184,063
Closed -$6.9M
REGN icon
77
Regeneron Pharmaceuticals
REGN
$77.4B
– –
-39,316
Closed -$14.8M
KA
78
DELISTED
Kineta, Inc. Common Stock
KA
– –
-2,143
Closed -$1.75M
ONCE
79
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-83,390
Closed -$4.29M
LOXO
80
DELISTED
Loxo Oncology, Inc
LOXO
– –
-152,185
Closed -$12.8M
1 2 3
4

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q1 2018 Portfolio in Review

As of Q1 2018, Sectoral Asset Management held 80 positions worth $912M, up 14% from $800M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Sectoral Asset Management deployed $107M of net new capital in Q1 2018, opening 13 new positions and adding to 28 existing holdings. Its largest new stake was Array Biopharma Inc: 1,031,650 shares worth $16.8M.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 92% a quarter earlier.

On the sell side, the largest reduction was Acceleron Pharma, an estimated $20.7M trimmed.

  • Sectoral Asset Management's largest Q1 2018 buy was Array Biopharma Inc: 1,031,650 shares worth $16.8M.
  • Sectoral Asset Management added most to Exact Sciences in Q1 2018, an estimated $18.6M increase.
  • Sectoral Asset Management's biggest Q1 2018 reduction was Acceleron Pharma, cutting an estimated $20.7M.
  • Sectoral Asset Management fully exited Regeneron Pharmaceuticals in Q1 2018, selling an estimated $14.8M.
  • Sectoral Asset Management's ten largest holdings make up 36% of its $912M portfolio in Q1 2018.
  • Sectoral Asset Management opened 13 new positions and closed 12 in Q1 2018.
  • Sectoral Asset Management's portfolio value rose 14% quarter-over-quarter to $912M.

Based on Sectoral Asset Management's 13F filing for Q1 2018, filed 15 May 2018.